Automated Cell Counter Market Analysis 2024-2033 | Growth, Size, Demand, Analysis, Insights

"The new report published by The Business Research Company, titled ""Automated Cell Counter Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the automated cell counter market size has grown strongly in recent years. It will grow from $5.08 billion in 2023 to $5.42 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The automated cell counter market size is expected to see strong growth in the next few years. It will grow to $7.02 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15730&type=smp

Rising Adoption Of Personalized Medicine Expected To Drive Growth In Automated Cell Counter Market
The rising adoption of personalized medicine is expected to propel the growth of the automated cell counter market going forward. Personalized medicine refers to tailoring medical treatment to each patient's individual characteristics, often based on genetic, environmental, and lifestyle factors. Personalized medicine applications are rising due to advancements in genetic research and technology, enabling more precise and effective treatments tailored to individual patient's unique genetic profiles and health data. Automated cell counting is utilized in personalized medicine to analyze patient-specific cell populations rapidly and accurately, aiding in the customization of treatments based on individual cellular profiles. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based hospital and healthcare company, the FDA approved 16 new personalized treatments for rare disease patients, a significant increase from the 6 approved in 2022. Therefore, the rising adoption of personalized medicine will drive the growth of the automated cell counter market.

AI-Powered Cell Culture Systems Revolutionize Lab Efficiency
Major companies operating in the automated cell counter market are focusing on the integration of intelligence algorithms and machine learning, such as the AI automated cell culture system, to optimize and automate the process of cell growth and scalability in biological research and biomanufacturing. An AI-automated cell culture system is a technology that utilizes artificial intelligence to autonomously monitor, manage, and optimize cell growth and maintenance in laboratory settings. For instance, in October 2023, Molecular Devices LLC, a U.S.-based supplier of analytical systems, introduced the CellXpress.ai automated cell culture system, an end-to-end, machine learning-enabled solution that automates demanding feeding and passaging schedules with an integrated incubator, liquid handler, and imager, giving scientists more time and autonomy in the lab. The hub incorporates cutting-edge technology designed to seamlessly oversee the entire cell journey. It boasts advanced machine learning-powered software that simplifies the navigation and supervision of complex cell culture processes, complete with pre-programmed protocols for generating both 2D and 3D models.

The automated cell counter market covered in this report is segmented -

1) By Product: Consumable Accessories, Instruments
2) By Application: Blood Analysis, Urine Analysis, Microbial Cell Count, Cell Line Viability, Other Applications
3) By End User: Pharmaceuticals And Biotechnology Companies, Hospitals, Diagnostics Laboratories, Research Institutes, Other End-Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=15730&type=discount

Major companies operating in the automated cell counter market are Thermo Fisher Scientific Inc., Abbott Laboratories, F.Hoffmann-La Roche Ltd., Danaher Corporation, Merck KGaA, BD Biosciences, GE HealthCare Technologies Inc., Corning Incorporated, Agilent Technologies Inc., Olympus Corporation, Nikon Corporation, PerkinElmer Inc., Sysmex Corporation, Bio-Rad laboratories Inc., HORIBA Ltd, Eppendorf, Tecan Group, Miltenyi Biotec, Luminex Corporation, Molecular Devices LLC, Chemometec A/S, NanoEnTek Inc, Sony Biotechnology Inc., Countstar Inc., Aligned Genetics Inc.

Contents of the report:
1. Executive Summary
2. Automated Cell Counter Market Report Structure
3. Automated Cell Counter Market Trends And Strategies
4. Automated Cell Counter Market - Macro Economic Scenario
5. Automated Cell Counter Market Size And Growth
…..
27. Automated Cell Counter Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/automated-cell-counter-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.